PEPID™ PDC beats ePocrates and nine other contenders in independent benchmark study of practical PDA prescribing solutions for doctors and nurses.
SKOKIE, IL, September 19, 2005 - PEPID LLC─the world’s leading developer of medical information and support tools─announced today that its drug database, PEPID Portable Drug Companion (PDC), is rated higher than ePocrates, PDRDrugs, Mobile-MDX, Mobile-PDR and other competitive products in an unsolicited study. The results of the study, led by Georgetown University Medical Center’s Dr. BjÖrn Knollmann, PhD, appear in the July 2005 issue of the Journal of the American Society for Clinical Pharmacology & Therapeutics.
“Obviously we’re very pleased with the study’s outcome and to see our Portable Drug Companion get the respect and attention we feel it deserves,” says Dr. Mark Rosenbloom, PEPID Founder and CEO. “Because our clinical database suites are so good…and our drugs fully-integrated into them, I suspect that the high quality of PDC has sort of been taken for granted. Now there is no question about who is number one in practical PDA drug information delivery.”
PEPID PDC scored highest on a combination of the features that mean the most to clinical practitioners including structured information on indications and dosing, side effects, drug interactions, and ‘special features’ like medical calculators and treatment algorithms. The study noted PEPID was the only product that provided information on the compatibility of various intravenous solutions.
A combination of Lexi-Drugs databases scored highest on comprehensiveness. But, the products are not fully-integrated into a clinical database and are geared more toward a pharmacist in a hospital setting, than the person actually doing the prescribing.
“When it comes to sheer content volume there’s no doubt that combined Lexi products will come out ahead – but, when it comes to useful data presented in a practical format there’s no doubt that PEPID is the winner,” adds John Wagner, President of PEPID. “With PEPID, doctors and nurses get the best of both worlds: a great clinical database and the number one rated drug module—PEPID PDC. They do not have to compromise one to get the other…or buy both separately.”
The study notes that “. . . ePocrates, which is currently the PDA reference that is most widely used among physicians, was average . . .” in both rational prescribing features and comprehensiveness. MobileMDR scored the lowest overall.
In a review of past studies, the report notes that “none of these studies considered the clinical utility of drug reference software for physicians, which may explain why PEPID PDC was not included in previous studies. PEPID PDC, which ranked highest in terms of rational prescribing features, was developed as a part of a suite of decision making products for physicians.”
Today, a majority of physicians use PDAs as a point-of-care, deicision-making resource. Seventy-two percent of these physicians consult their handheld devices for drug related information. The study, Personal digital assistant-based drug reference software as tools to improve traditional prescribing: Benchmark criteria and performance, Knollmann et al, was supported by the National Institute of Health and issued from the Division of Clinical Pharmacology and Center for Drug Development Sciences, Georgetown University Medical Center.
To view the entire study, please link to the PDF version at: www.pepid.com/pdcreview.pdf"
Fig 1. Comparison of rational prescribing features. The following categories from Table I are included in the score for rational prescribing features: structured information on indications and dosing (0–6 points), side effects (0–4 points), drug interactions (0–4 points), and special features (0–8 points).
About PEPID and PEPID PDC
PEPID, LLC was founded in 1994 by Dr. Mark Rosenbloom, a board-certified emergency physician and faculty member at Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. PEPID’s medical reference software is designed to assist in the reduction of medical errors and result in improved patient outcomes. Suites designed for physicians, nurses, students, paramedics and pharmacists provide access to current pharmacological and clinical information at the point-of-care via handheld computers and the Internet. PEPID PDC is available as a stand alone product and is continually updated. More information about PEPID products, can be found at www.pepid.com
PEPID™, product names and logotypes are trade marks of PEPID LLC.
The article is copyright © 2005 by the American Society for Clinical Pharmacology and Therapeutics. Other product and corporate names may be registered trade marks of their respective owners.
Copyright © 2000-2005. All rights reserved.